In this ToxChats© podcast, we spoke with Dr. René Meisner, Head of Safety Assessment at Denali Therapeutics, on using both transgenic and disease mouse models in a drug development program. Topics include considerations for program design, regulatory interactions, and the role of these mice moving forward.
ToxChats© episodes report on cutting-edge news in toxicological research from around the globe, and feature interviews with experts and reviews of current advances in toxicology. Tune in to learn about breakthroughs and regulatory developments in toxicological research, and more! We welcome any feedback or suggestions for future topics.